Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Noninvasive positron emission tomography (PET) imaging of Sleeping Beauty (SB) modified CD19-specific T cells expressing HSV1-Thymidine kinase
Pallavi R.Manuri, PhD. Department of Pediatrics Research
Adoptive Cell Therapy
• Development of engineered T cells using – T-cell receptors– Chimeric antigen
receptors (CARs)• Methods of genetic
moditication– Viral – No-viral
CD19-specific CAR
Rationale
However, to improve the design, application and evaluation of adoptive T-cell therapy requires monitoring methods that can
• Detect
• Locate and
• Serially quantify the cell-mediated immune responses
Rationale
Currently monitoring methods are chiefly invasive techniques
•Histology
•Flow cytometry
•Q-PCR and/cytokine analysis
In contrast, Positron emission tomography (PET) is a•Noninvasive, accurate, and
•Sensitive whole-body imaging technology allowing
•Repetitive measurement in vivo
Herpes Simplex Virus 1- thymidine kinase (HSV1-tk)
• Expression of reporter genes and use of corresponding reporter probes (radiotracers) labeled with positron-emitting radionuclides.
18F-FEAU18F-FHBG
TK
TK
TKTK
TK
TK
P
P
P
P
The specificity and/or sensitivity of HSV1-tk were altered by•Mutations in the nucleoside binding region (HSV1-sr39tk)
•Inactivation of the nuclear localization signal (NLS) of HSV1-tk Arg25-26 were replaced by Gly25-26
•Addition of the nuclear export sequence (NES)
Generation of CD19-specific T cells capable of being imaged non-invasively by PET
Cytoplasm
NucleusTransposaseTransposase
TransposonTransposon
Gene XCAR #1
mRNA
SB11 protein
TransposonTransposon
Gene XCAR #2
CD19RCD28mZ(CoOp)/pSBSO
Kan/R
CD19RCD28mZ(CoOp)BGH
hEF-1alpha/p
Kan/p
CoIE1
IR/DR
IR/DR
Flag-NES-NLSm-TK(CoOp)-Hygro/pSBSO
Kan/R
NES-NLSm-TK (CoOp)
Hygro
3(flag)
LinkerBGH
hEF-1alpha/pKan/p
EM7
CoIE1
IR/DR(L)
IR/DR(R)pCMV-SB11
4732bp
APr
Transposase
SV40 polyA
CMV promoter/enhancer
Scheme of expansion of T cells on artificial antigen presenting cells
Co-expression of CD19-specific CAR and TK
CAR+TK- CAR+TK+
FLAG
CA
R
98.9 0.44
0.000.63 0.01
2.85 96.8
0.37
Redirected specificity of CD19CAR+TK+ T cells
20:1
10:1 5:1 2.5:1
1.25:1
0
20
40
60
80Nalm-6Daudi--2mU251TtCD19U251T
Effector:Target ratio
% S
peci
fic L
ysis
] CD19+
Specificity towards nucleoside analogs
0.0 uM
0.01u
M0.1
uM1.0
uM10
.0 uM
0
50
100
150TK negativeNES-(NLMm)TKHy
Ganciclovir (M)
% T
cel
l Sur
viva
l
Sensitivity towards Ganciclovir
CAR+TK-
CAR+TK+
In vitro accumulation of 3H-FEAU
TK negati
ve
NES-(NLS)m
-TKHy
0
10
20
30
40
50
Cel
l/Med
ia ra
tio
CAR+TK+
CAR+ TK-
In Vivo Imaging of CD19CAR+TK+ T cells with PET
7.5x 106 T cells subcutaneously and 100Ci of 18F-FEAU intravenously
Axial view Coronal view Saggital view
In Vivo Imaging of CD19CAR+TK+ T cells with PET
15x 106 T cells subcutaneously
Axial view Coronal view Saggital view
3 dimensional reconstruction of CD19CAR+TK+T cells imaged by PET
Summary
• Co-expression of a CD19-specific CAR and HSV1-tk by SB transposition.
• SB modified CD19CAR+TK+ T cells – visualized spatio-temporally by PET using
18F-FEAU – ablated in the presence of ganciclovir and
also– Have the ability to kill CD19+ tumor targets.
Implication
Clinical Significance: in non-invasively monitoring the persistence and trafficking SB modified adoptively transferred CD19-specific T cells.
Ongoing work: in vivo tumor model is being worked out
Thanks
Cooper labKirsten SwitzerTiejuan MiLing ZhangHarjeet SinghHelen Huls
• Carl June• Bruce Levine
Gelovani labAmer NajjarLeo Flores II
Perry Hackett
David Largaespada